Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years - Pennell, D.; Porter, J.B.; Cappellini, M.D.; Chan, L.L.; El-Beshlawy, A.; Aydinok, Y.; Ibrahim, H.; Li, Chi-Kong; Viprakasit, V.; Elalfy, M.S.; Kattamis, A.; Smith, G.; et al. (Amer Soc Hematology, 2010)